A detailed history of Perfromance Wealth Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Perfromance Wealth Partners, LLC holds 8,949 shares of PFE stock, worth $234,553. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,949
Previous 11,173 19.91%
Holding current value
$234,553
Previous $312,000 17.31%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$27.7 - $31.39 $61,604 - $69,811
-2,224 Reduced 19.91%
8,949 $258,000
Q2 2024

Jul 19, 2024

BUY
$25.26 - $29.6 $34,681 - $40,640
1,373 Added 14.01%
11,173 $312,000
Q1 2024

Apr 30, 2024

SELL
$25.89 - $29.73 $28,634 - $32,881
-1,106 Reduced 10.14%
9,800 $271,000
Q4 2023

Jan 22, 2024

SELL
$26.13 - $33.94 $36,791 - $47,787
-1,408 Reduced 11.43%
10,906 $313,000
Q3 2023

Oct 30, 2023

SELL
$32.09 - $37.51 $48,135 - $56,265
-1,500 Reduced 10.86%
12,314 $408,000
Q2 2023

Jul 13, 2023

BUY
$36.12 - $41.79 $134,438 - $155,542
3,722 Added 36.88%
13,814 $506,000
Q1 2023

Apr 20, 2023

SELL
$39.39 - $51.28 $61,133 - $79,586
-1,552 Reduced 13.33%
10,092 $411,000
Q4 2022

Jan 19, 2023

SELL
$41.75 - $54.5 $37,449 - $48,886
-897 Reduced 7.15%
11,644 $0
Q3 2022

Oct 17, 2022

SELL
$43.76 - $53.42 $2,056 - $2,510
-47 Reduced 0.37%
12,541 $549,000
Q2 2022

Jul 15, 2022

SELL
$46.53 - $55.17 $29,500 - $34,977
-634 Reduced 4.8%
12,588 $660,000
Q1 2022

Apr 21, 2022

BUY
$45.75 - $56.69 $56,547 - $70,068
1,236 Added 10.31%
13,222 $684,000
Q4 2021

Feb 03, 2022

BUY
$41.32 - $61.25 $495,261 - $734,142
11,986 New
11,986 $708,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Perfromance Wealth Partners, LLC Portfolio

Follow Perfromance Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perfromance Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perfromance Wealth Partners, LLC with notifications on news.